
Canada-based Acuitas Therapeutics Inc has sued Arbutus Biopharma Corporation (NASDAQ:ABUS) in Manhattan federal court, seeking to head off claims that the vaccine infringes Arbutus' patents, reports Reuters.
Acuitas, Canada-based biotech, makes mRNA-delivery technology for Pfizer Inc's (NYSE:PFE) COVID-19 vaccine.